← FDA Drug Approvals (Drugs@FDA)

DEGARELIX ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Approved 2025-08-18

Drug application

FDA Application #

ANDA215791

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEGARELIX ACETATE

Generic name

Degarelix Acetate

Active ingredients

DEGARELIX ACETATE

Dosage form

NJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

—

Marketing status

None (Tentative Approval)

Sponsor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

First approval

2025-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown